DAILYCALLER (Spencer Lombardo) - Federal Court Dismisses Pro-Abortion Groups’ Lawsuit Seeking To Ensure Access To Public Funds
‘That is the point of a competitive process—to identify the applicants best suited for the grant’
‘That is the point of a competitive process—to identify the applicants best suited for the grant’
In its original complaint, Louisiana argued the Biden administration expanded access to mifepristone without properly considering potential safety risks. The state also argued the policy violated the Comstock Act, which generally prohibits sending abortion drugs by mail.
Dr. Eithan Haim discusses a new Medicaid rule blocking taxpayer funding for gender transition surgeries for minors and President Donald Trump's stance on the issue on ‘The Bottom Line.’ #fox #foxbusiness #media #breakingnews #us #usa #new #news #breaking #thebottomline #medicaid #healthcare #gendertransition #transgender #minors #taxpayerfunding #trump #donaldtrump #politics #political #politicalnews #government #eithanhaim #dagenmcdowell #brianbrenberg
Transgender rights advocates said the new rule would face a legal challenge.
The Centers for Medicare and Medicaid Services (CMS) ended a Biden administration policy that required racial considerations be made to determine who was eligible to get a kidney transplant. CMS published a final rule Monday governing the Increasing Organ Transplant Access (IOTA) Model, a mandatory, six-year program that ostensibly sought to “increase access to kidney […]
The groups sued over a federal rule limiting student loan borrowing for some graduate degree programs that impact healthcare professionals.
Dr. Mehmet Oz, administrator of the Centers for Medicare and Medicaid Services (CMS), leads the White House press briefing. Oz's turn at the podium comes a day after the Trump administration issued a final rule requiring most Medicaid beneficiaries ages 19-64 to provide proof they are working, complete community service or participate in a work program to be awarded benefits. #droz #trump #medicaid
The U.S. Supreme Court temporarily paused a lower court decision on Monday that blocked a federal rule allowing harmful abortion drugs to be shipped by mail. In his order, Associate Justice Samuel Alito entered an administrative stay (“pause”) of a Friday ruling by the 5th Circuit Court of Appeals. That unanimous decision by a three-judge […]
State of the Union: The court ruled that allowing the pills to be mailed undermines the state’s abortion law. The post FDA Blocks Mail Distribution of Abortion Pills appeared first on The American Conservative .
A federal appeals court on Friday blocked the mailing of mifepristone prescriptions, sharply curtailing access to one of the most common methods of abortion in the United States. The unanimous ruling by a three-judge panel of the Fifth U.S. Circuit Court of Appeals requires the abortion pill to be dispensed only in person at clinics, overruling Food and Drug Administration regulations that allowed it to be distributed by mail. Judge Kyle Duncan wrote that mailing the drug into Louisiana undermines the state’s abortion ban. Danco Laboratories, the manufacturer of mifepristone, has appealed to the U.S. Supreme Court to overturn the decision. The Supreme Court unanimously ruled against an attempt by pro-life groups to restrict access…Open
The Fifth Circuit Court’s ruling, which is being appealed, reinstates a requirement that patients visit a health care provider in person to obtain mifepristone, upending abortion access in the United States.